Anakinra
Frontiers | IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives | Immunology
Therapy of autoinflammatory syndromes - ScienceDirect
Blocking IL-1 to prevent respiratory failure in COVID-19 | Critical Care | Full Text
Current mechanisms of IL-1-targeted therapy. Anakinra, a recombinant... | Download Scientific Diagram
Mode of action of IL-1 and its inhibitors. (A) The IL-1 inhibitors... | Download Scientific Diagram
Mechanism of action of IL-1 inhibitors - UpToDate
Anakinra Drugbank ID : DB ppt download
Rheumatoid_Arthritis_Treatments_with_Biologics
Strategies for IL-1 blockade with Anakinra and Canakinumab. (A)... | Download Scientific Diagram
Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection | SpringerLink
Figure 2 from Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences | Semantic Scholar
KINERET® (anakinra) Official HCP Website | About
Current mechanisms of IL-1-targeted therapy. Anakinra, a recombinant... | Download Scientific Diagram
![IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension](https://www.ahajournals.org/cms/asset/c514bc66-af77-4759-b7f9-1503e4f6084b/hypertensionaha.119.13982.fig04.jpg "IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension")
IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies | Bone Research
Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis. - Abstract - Europe PMC
Anakinra - Wikipedia
![Supplemental Materials for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5710422a-7b47-4eeb-ac52-48a5a375394e/gr1_lrg.jpg "Supplemental Materials for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents")
Supplemental Materials for ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents
Frontiers | Anakinra Therapy for Non-cancer Inflammatory Diseases | Pharmacology
Frontiers | Controlling Cytokine Storm Is Vital in COVID-19 | Immunology
Anakinra: Uses, Interactions, Mechanism of Action | DrugBank Online
Mechanism of action of anakinra. Both IL-1α and IL-1β act through IL-1... | Download Scientific Diagram
